Compass Therapeutics, Inc.
USD2.23
+0.07 (+3.47%)
CEO
Thomas J. Schuetz
IPO Date
2021-04-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.16
Prev. Close
$2.16
Day Low
$2.13
Day High
$2.24
52W Low
$1.61
52W High
$6.88
Market Cap
$0.31B
Volume
0.98M
| -4.0 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -28.6% | -27.1% | 0.01 | 19.73 | -4.7 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -21.6% | -19.6% | 0.02 | 12.05 | -13.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -58.7% | -53.4% | 0.03 | 13.84 | -2.4 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -73.9% | -56.8% | 0.23 | 4.97 | -16.2 |
| 31 Mar 2020 | FY | 0.0% | 0.0% | 29.3% | -114.4% | -0.13 | 2.67 | -12.7 |
| 31 Mar 2019 | FY | 0.0% | 0.0% | 45.2% | -59.2% | -0.17 | 6.96 | -1.1 |
| -15.8 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -6.8% | -6.2% | 0.05 | 17.82 | -8.5 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -21.3% | -17.0% | 0.11 | 7.66 | -4.5 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -15.1% | -12.7% | 0.06 | 8.33 | -3.9 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -12.0% | -10.7% | 0.05 | 14.96 | -3.3 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -7.6% | -7.0% | 0.05 | 31.84 | -6.0 |
| 30 Jun 2024 | Q2 | 100.0% | -1538.4% | -8.9% | -8.4% | 0.01 | 16.15 | -2.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -6.9% | -6.7% | 0.01 | 40.74 | -5.8 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -9.0% | -8.6% | 0.01 | 19.73 | -3.7 |